Login to Your Account

FDA's Blessing, Shire Details Keep New River Riding High

By Randall Osborne

Wednesday, October 11, 2006
Despite the likelihood that its drug for attention deficit hyperactivity disorder might fall into the same federal abuse category as competitors' therapies, New River Pharmaceuticals Inc. enjoyed another stock boost Tuesday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription